Skip to main content
Equibles

FMR LLC

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 315066 BOSTON, MA
Back to ENTA Full portfolio

Position in ENTA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$430,182
+$85,738 QoQ
Shares Held
29,505
+8.2% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 122 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. ENTA ranks #229 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in ENTA

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $430,182 29,505
2026-03-31 $344,444 27,272
2025-12-31 $67,999 4,312
2025-09-30 $21,365 1,785
2025-06-30 $13,539 1,791
2025-03-31 $34,632 6,274
2024-12-31 $446,107 77,584
2024-09-30 $510,757 49,301
2024-06-30 $537,762 41,462
2024-03-31 $688,290 39,421
2023-12-31 $288,557 30,665
2023-09-30 $389,375 34,859
2023-06-30 $3,001,521 140,258
2023-03-31 $4,856,884 120,101
2022-12-31 $12,315,844 264,743
2022-09-30 $16,115,749 310,695
2022-06-30 $16,560,240 350,333
2022-03-31 $17,237,802 242,172
2021-12-31 $897 12
2021-09-30 $681 12
2021-06-30 $528 12
2020-06-30 $2,711 54
2020-03-31 $627,188 12,195